Ayurvedic, Siddha or Unani drugs are sold under license given by the State Licensing Authorities. Rule 158 B of the Drugs and Cosmetics Rules, 1945 prescribes regulatory requirements including submission of proof of safety and effectiveness for licensing of Ayurvedic, Siddha or Unani drugs. Enforcement of these provisions is under purview of the State Licensing Authorities appointed by the State Governments. Directive is issued to all state Licensing Authorities, Research Councils, National Institutes, Health Universities and Ayurvedic, Siddha or Unani Drugs manufacturers Associations to ensure registration of the clinical trials of AYUSH in the Clinical Trials Registry of India (CTRI).
This information was given by the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Rajya Sabha today.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)